CHM Cannabis
Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, GOLD DIGGAA, FreezeThese, euroconversions
Search This Board: 
Last Post: 12/11/2018 9:56:34 AM - Followers: 300 - Board type: Free - Posts Today: 2

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing

CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 
 (as of May 5th, 2018)
Warrants Issued but not Exercised  
Options Issued but not Exercised  7,076,000
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent 5M Shares


Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLOZF News: Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer 11/15/2018 08:45:00 AM
BLOZF News: Cannabix Technologies Comments on Legalization of Marijuana in Canada, Impaired Driving and Workplace Safety 10/16/2018 08:45:00 AM
BLOZF News: Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development 08/27/2018 08:45:00 AM
BLOZF News: Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development 06/18/2018 08:45:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#24317  Sticky Note Cannabix Technologies Engages MistyWest - Provides Development Update FreezeThese 11/15/18 09:00:24 AM
#22892  Sticky Note Patent Pending Cannabis Drug Detection Device: I recommend you euroconversions 07/09/18 04:39:05 PM
#21936  Sticky Note Cannabix Technologies Files FAIMS Cannabis Detection Patent shell3 04/16/18 04:20:52 PM
#24400   2 Words 2 Sum Up All Things In AMG 12/11/18 09:56:34 AM
#24399   I can hear Bob Marley - Misty Morning whitehotcoal 12/11/18 09:22:31 AM
#24398   Are we there yet? Are we there yet? Carthnel 12/10/18 02:01:51 PM
#24397   Very Nice... I Like That. rjp15 12/10/18 12:34:58 PM
#24396   Wow AMG ... got me feel' alittle Misty.... smoki 12/08/18 09:51:32 PM
#24395   I Open Minds Eyes. AMG 12/08/18 09:43:18 PM
#24394   Loving the new attitude around here. GVX808 12/08/18 09:31:06 PM
#24393   P.S.S.S. F.Y.I. AMG 12/08/18 10:45:59 AM
#24392   P.S.S. F.Y.I. AMG 12/08/18 04:36:13 AM
#24391   See Misty West Corporate Video @ 18 Secs AMG 12/07/18 08:22:00 PM
#24389   View From The Desks @ Misty West AMG 12/07/18 02:54:49 PM
#24388   Not only is it not a big deal, AMG 12/07/18 02:01:35 PM
#24387   It's really not a big deal at all. Zlinger 12/07/18 01:47:32 PM
#24386   They are right above a hot yoga studio GOLD DIGGAA 12/07/18 01:17:40 PM
#24384   Have not seen 500k shares move in a Carthnel 12/07/18 12:48:59 PM
#24382   Thankful for the Marlboro man today.... keep' n smoki 12/07/18 12:25:01 PM
#24381   Your right Shell, I’m was running memory banks.. Carthnel 12/07/18 11:09:14 AM
#24380   Those are for a Patent Awarded shell3 12/07/18 10:58:46 AM
#24379   Yes, key words in fifth report will read Carthnel 12/07/18 10:51:15 AM
#24378   I forgot to mention in previous post that Ragstoriches465 12/07/18 10:48:06 AM
#24377   If Yost and co have ironed out manufacturability mfascuba 12/07/18 10:45:21 AM
#24376   Agreed. Yost and friends created the guts, mfascuba 12/07/18 10:40:13 AM
#24375   I would surmise that Yost and team came Ragstoriches465 12/07/18 10:36:08 AM
#24374   It's the Shareholder's monster at this point in smoki 12/07/18 09:35:21 AM
#24373   I was hoping Agilent was just going to Carthnel 12/07/18 09:28:32 AM
#24372   Magical power's at Misty West... Yost could'nt get? smoki 12/07/18 09:19:06 AM
#24371   Design Vs. Production... two different monsters, 1 of Carthnel 12/07/18 09:13:45 AM
#24370   Anyone else concerned about the Misty West creating smoki 12/07/18 09:08:38 AM
#24369  Restored Sir...a follow up from earlier (Btec). I just AMG 12/06/18 08:40:44 PM
#24368   Lmao probably the funnest DD I have seen Haas_27 12/06/18 05:05:12 PM
#24367   I am definitely glad we’re in the production GVX808 12/06/18 12:07:46 PM
#24366   Thank god we are at Misty.... Carthnel 12/06/18 11:26:03 AM
#24365   Added here FreezeThese 12/06/18 10:27:22 AM
#24364   Lol for a minute there, I thought I Zlinger 12/05/18 06:56:14 PM
#24363   oopsed, wrong board! apologies geodcan 12/05/18 05:29:18 PM
#24362   It's bargain day today. Tinley got caught geodcan 12/05/18 05:26:45 PM
#24361   101,942,374 common shares for December 5, 2018 shell3 12/05/18 12:51:48 PM
#24360   Yes Bazwar6 12/05/18 09:59:05 AM
#24359   Is there trading CAD side today? FreezeThese 12/05/18 09:12:22 AM
#24358   That’s exactly my plan too lol a couple Haas_27 12/04/18 10:44:26 AM
#24357   If the share prices can remain low for ale-tea 12/04/18 10:32:32 AM
#24356   I will be very surprised if we don't GVX808 11/30/18 07:54:33 PM
#24355   Thank you yet again Shell, I could Carthnel 11/30/18 05:20:34 PM
#24354   $1.60 CAD is $1.20 USD shell3 11/30/18 12:21:45 PM
#24353   We have a Monthly coming next week and shell3 11/30/18 12:09:09 PM
#24352   Shell, what is the count? What Dates Carthnel 11/30/18 09:54:16 AM
#24351   Here is a new refresher drt1111 11/30/18 09:48:49 AM
#24350   $$$$BLOZF$$$$ euroconversions 11/28/18 08:59:27 AM
#24349   CANNABIX TECHNOLOGIES INC ORDINARY SHAR (OTCMKTS:BLOZF) had an FreezeThese 11/28/18 08:02:04 AM
#24348   $BLOZF gonna $BLO — $MARS shell3 11/26/18 02:16:44 PM